Ascend Metformin Tablets Recall: Foreign Amlodipine Tablets Found
Ascend Laboratories recalls 500mg Metformin tablets due to reports of Amlodipine tablets contaminating the product. This is a prescription-only medication.
Lower-risk recall
Presence of Foreign Tablets/Capsules; report of Amlodipine Tablets found in 1000 count bottles of Metformin Hydrochloride Tablets USP
Contact the company
What happened, in plain English
Ascend Laboratories is recalling 500mg Metformin Hydrochloride Tablets because some bottles contain foreign Amlodipine tablets. This could lead to unintended medication intake if taken without knowing the mix-up. Read more at govinfonow.com/recall/42265-ascend-metformin-tablets-recall-foreign-amlodipine-tablets-found.
Source Summary by GovInfoNow · govinfonow.com/recall/42265-ascend-metformin-tablets-recall-foreign-amlodipine-tablets-found · Updated October 9, 2026 · FDA enforcement record: FDA #D-0163-2017
Cite this page
“Ascend Metformin Tablets Recall: Foreign Amlodipine Tablets Found.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42265-ascend-metformin-tablets-recall-foreign-amlodipine-tablets-found. Based on FDA recall #D-0163-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0163-2017%22&limit=1).
Why it’s dangerous
The recall reports that some bottles of Metformin Hydrochloride Tablets contain Amlodipine tablets as foreign material. This could happen during manufacturing or distribution, leading to patients taking an unintended medication.
Who’s affected
Prescription holders of Metformin Hydrochloride Tablets 500mg, 1000 tablets, manufactured by Alkem Laboratories Ltd. in Mumbai, India. Those who have taken the product without noticing the foreign tablets are at risk of unintended medication intake.
How to tell if you have this one
Check for the product name 'Metformin Hydrochloride Tablets, USP 500 mg, 1000 tablets' with NDC code 67877-217-10. The lot number is 6121056, expiring May 2019.
- Brand
Ascend Laboratories- Category
Drug
What to do — step by step
Check Your Product
Look for the NDC code 67877-217-10 and lot number 6121056 on the packaging.
Where it went and when
Where it was distributed
Distributed in 5 states.
FDA distribution: “AL, FL, GA, SC & TN” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Alabama, Florida, Georgia, South Carolina, Tennessee.
Recall timeline
FDA terminated this recall 7 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
What should I do if I have this product?
Check the NDC code and lot number on the packaging to see if it's affected. If it matches, contact your healthcare provider.
Similar recalls
Other Ascend Laboratories recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0163-2017 (November 2, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0163-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.